Hikma Pharmaceuticals Dividend
Hikma Pharmaceuticals Dividend history 18 years & estimates 2024 to 2027
Dividend Analysis of the Hikma Pharmaceuticals Stock
| Current dividend yield | 1.02 % |
| Dividendenrendite 5 Jahre | 2.41 % |
| Dividend Yield 10Y | 2.03 % |
| Payout 3Y | 6.17 % |
When does Hikma Pharmaceuticals pay a dividend?
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2024 |
GBP0.32
GBP0.32
|
Aug 15 2024
Aug 15 2024
Sep 20 2024
Aug 15 24
Sep 20 24 |
Sep 20 2024 |
-
-
|
| 2024 |
GBP0.47
GBP0.47
|
Mar 21 2024
Mar 21 2024
May 03 2024
Mar 21 24
May 03 24 |
May 03 2024 |
-
-
|
| 2023 |
GBP0.25
GBP0.25
|
Aug 10 2023
Aug 10 2023
Sep 15 2023
Aug 10 23
Sep 15 23 |
Sep 15 2023 |
-
-
|
| 2023 |
GBP0.37
GBP0.37
|
Mar 23 2023
Mar 23 2023
May 05 2023
Mar 23 23
May 05 23 |
May 05 2023 |
-
-
|
| 2022 |
GBP0.19
GBP0.19
|
Aug 18 2022
Aug 18 2022
Sep 20 2022
Aug 18 22
Sep 20 22 |
Sep 20 2022 |
-
-
|
| 2022 |
GBP0.36
GBP0.36
|
Mar 17 2022
Mar 17 2022
Apr 28 2022
Mar 17 22
Apr 28 22 |
Apr 28 2022 |
-
-
|
| 2021 |
GBP0.18
GBP0.18
|
Aug 19 2021
Aug 19 2021
Sep 20 2021
Aug 19 21
Sep 20 21 |
Sep 20 2021 |
-
-
|
| 2021 |
GBP0.34
GBP0.34
|
Mar 18 2021
Mar 18 2021
Apr 26 2021
Mar 18 21
Apr 26 21 |
Apr 26 2021 |
-
-
|
| 2020 |
GBP0.16
GBP0.16
|
Aug 20 2020
Aug 20 2020
Sep 21 2020
Aug 20 20
Sep 21 20 |
Sep 21 2020 |
-
-
|
| 2020 |
GBP0.3
GBP0.3
|
Mar 19 2020
Mar 19 2020
May 07 2020
Mar 19 20
May 07 20 |
May 07 2020 |
-
-
|
How much dividend does Hikma Pharmaceuticals pay?
Hikma Pharmaceuticals most recently paid a dividend of GBP0.32. Hikma Pharmaceuticals paid a Dividend of GBP0.62 Per Share in the financial year 2023. With a stock price of GBP17.94 at Nov 14 2024, the current dividend yield is 3.46% (calculation: GBP0.62 / GBP17.94 = 3.46%). No special dividend was paid.
What is the Hikma Pharmaceuticals Dividend Yield and payout ratio?
The average Hikma Pharmaceuticals dividend yield over the last 5 years is 2.83% and the average over the last 10 years is 2.32%.
The payout ratio of Hikma Pharmaceuticals in relation to the last financial year is 89.86%. The payout ratio smoothed over 3 years is 62.59%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | Hikma Pharmaceuticals |
|---|---|
| Current dividend yield | 3.46% |
| Dividend Yield 5Y | 2.83% |
| Dividend Yield 10Y | 2.32% |
| Payout 1Y | 89.86% |
| Payout 3Y | 62.59% |
Is the Hikma Pharmaceuticals dividend safe? Continuity & Dividend Growth
Is the Hikma Pharmaceuticals dividend safe?
Hikma Pharmaceuticals has been paying a dividend for 18 years and has not lowered the dividend for 7 years (dividend continuity). As a result, the dividend was recently increased 7-times.
The Dividend Growth in relation to the previous financial year amounts to 12.73%. The average Hikma Pharmaceuticals Dividend Growth over the last 5 years is 12.12%. The average for the last 10 years is 21.87%.
| Metric | Hikma Pharmaceuticals |
|---|---|
| Increased | 7 Years |
| Continuity | 7 Years |
| Paid | 18 Years |
| Growth 1Y | 12.73% |
| Growth 5Y | 12.12% |
| Growth 10Y | 21.87% |
Continuity
Hikma Pharmaceuticals has been paying a dividend for 18 years and has not lowered the dividend for 7 years (dividend continuity). As a result, the dividend was recently increased 7-times.
Dividend Growth
The Dividend Growth in relation to the previous financial year amounts to 12.73%. The average Hikma Pharmaceuticals Dividend Growth over the last 5 years is 12.12%. The average for the last 10 years is 21.87%.
Hikma Pharmaceuticals Stock Forecast 2024
On the stock exchange, the Hikma Pharmaceuticals stock (ISIN: GB00B0LCW083) is not traded as a top scorer in November 2024 according to the dividend strategy.
The stock price of Hikma Pharmaceuticals 5.64% has risen since the beginning of the year 2024. However, the return generated in the past says nothing about the future return. You can find the Hikma Pharmaceuticals stock price in real time at the top of the page.
Hikma Pharmaceuticals (symbol: HIK) is valued at a Price / Earnings Ratio (P/E ratio) of 17.60 and a price/sales ratio (P/S ratio) of 1.66 valued. Based on analyst estimates, the Hikma Pharmaceuticals stock forecast 2024 of the current financial year corresponds to a valuation of 11.75 according to P/E ratio and 1.69 according to P/S.
| Metric | Hikma Pharmaceuticals |
|---|---|
| Dividend Score | ??/15 |
| Performance 2024 |
5.64%
|
| P/E TTM | 17.60 |
| P/S TTM | 1.66 |
| P/E forward | 11.75 |
| P/S forward | 1.69 |
Hikma Pharmaceuticals (symbol: HIK) is valued at a Price / Earnings Ratio (P/E ratio) of 17.60 and a price/sales ratio (P/S ratio) of 1.66 valued. Based on analyst estimates, the Hikma Pharmaceuticals stock forecast 2024 of the current financial year corresponds to a valuation of 11.75 according to P/E ratio and 1.69 according to P/S.
Discover more Dividend Stocks
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
